Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Copaxone All-Case Use-Result Investigation for Prevention of Relapse of Multiple Sclerosis
jRCT1080223004Completed
- Sponsor
- Takeda
- Start
- Nov 2015
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Open-label, single-arm trial of glatiramer acetate in multiple sclerosis (MS), sponsored by Takeda. Started Nov 2015; status: completed.
02
Drugs
glatiramer acetate
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on jRCT1080223004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080223004.